A. E. M. Stroomer

592 total citations
13 papers, 445 citations indexed

About

A. E. M. Stroomer is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, A. E. M. Stroomer has authored 13 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 5 papers in Physiology. Recurrent topics in A. E. M. Stroomer's work include Metabolism and Genetic Disorders (5 papers), Biochemical and Molecular Research (5 papers) and Biochemical effects in animals (4 papers). A. E. M. Stroomer is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Biochemical and Molecular Research (5 papers) and Biochemical effects in animals (4 papers). A. E. M. Stroomer collaborates with scholars based in Netherlands. A. E. M. Stroomer's co-authors include N. G. G. M. Abeling, Albert H. Gennip, Henk van Lenthe, André B. P. Kuilenburg, Annet M. Bosch, Hennie Knoester, Frits A. Wijburg, W. Ludo van der Pol, Lodewijk IJlst and Gepke Visser and has published in prestigious journals such as Biochemical Journal, Human Molecular Genetics and Clinical Chemistry.

In The Last Decade

A. E. M. Stroomer

13 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. E. M. Stroomer Netherlands	10	271	185	80	74	66	13	445
Pascale Delonlay France	11	304 1.1×	255 1.4×	33 0.4×	62 0.8×	13 0.2×	13	530
Ángela Arias Spain	18	290 1.1×	278 1.5×	104 1.3×	51 0.7×	15 0.2×	31	673
L. Kierat Switzerland	13	271 1.0×	266 1.4×	139 1.7×	90 1.2×	10 0.2×	26	496
Daniela R. Melo Brazil	8	271 1.0×	154 0.8×	38 0.5×	23 0.3×	23 0.3×	9	404
Maria Luı́s Cardoso Portugal	15	257 0.9×	294 1.6×	89 1.1×	56 0.8×	14 0.2×	29	542
P. Schlesinger Australia	11	157 0.6×	157 0.8×	28 0.3×	52 0.7×	87 1.3×	14	550
H. R. Scholte Netherlands	13	370 1.4×	293 1.6×	32 0.4×	35 0.5×	11 0.2×	17	495
C. Jakobs Netherlands	11	218 0.8×	230 1.2×	81 1.0×	76 1.0×	8 0.1×	13	477
Ertan Mayatepek Germany	9	439 1.6×	381 2.1×	85 1.1×	70 0.9×	10 0.2×	12	716
Alecia Willis United States	14	373 1.4×	132 0.7×	27 0.3×	61 0.8×	14 0.2×	17	643

Countries citing papers authored by A. E. M. Stroomer

Since Specialization

Citations

This map shows the geographic impact of A. E. M. Stroomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. M. Stroomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. M. Stroomer more than expected).

Fields of papers citing papers by A. E. M. Stroomer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. M. Stroomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. M. Stroomer. The network helps show where A. E. M. Stroomer may publish in the future.

Co-authorship network of co-authors of A. E. M. Stroomer

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. M. Stroomer. A scholar is included among the top collaborators of A. E. M. Stroomer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. M. Stroomer. A. E. M. Stroomer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bosch, Annet M., N. G. G. M. Abeling, Lodewijk IJlst, et al.. (2010). Brown‐Vialetto‐Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. Journal of Inherited Metabolic Disease. 34(1). 159–164. 167 indexed citations

Kuilenburg, André B. P., A. E. M. Stroomer, Annet M. Bosch, & M. Durán. (2008). ß-Alanine and ß-Aminoisobutyric Acid Levels in Two Siblings With Dihydropyrimidinase Deficiency. Nucleosides Nucleotides & Nucleic Acids. 27(6-7). 825–829. 9 indexed citations

Kuilenburg, André B. P., A. E. M. Stroomer, N. G. G. M. Abeling, & Albert H. Gennip. (2006). A Pivotal Role for β-Aminoisobutyric Acid and Oxidative Stress in Dihydropyrimidine Dehydrogenase Deficiency?. Nucleosides Nucleotides & Nucleic Acids. 25(9-11). 1103–1106. 8 indexed citations

Kuilenburg, André B. P., Rutger Meinsma, Birgit Assmann, et al.. (2004). β-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Human Molecular Genetics. 13(22). 2793–2801. 60 indexed citations

Kuilenburg, André B. P., A. E. M. Stroomer, Henk van Lenthe, N. G. G. M. Abeling, & Albert H. Gennip. (2004). New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?. Biochemical Journal. 379(1). 119–124. 52 indexed citations

Kuilenburg, André B. P., et al.. (2001). Simultaneous determination of F-β-alanine and β-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 759(1). 51–61. 11 indexed citations

Kuilenburg, André B. P., Godefridus J. Peters, A. H. van Gennip, et al.. (1998). No Circadian Variation of Dihydropyrimidine Dehydrogenase, Uridine Phosphorylase, β-Alanine, and 5-Fluorouracil During Continuous Infusion of 5-Fluorouracil. Advances in experimental medicine and biology. 431. 811–816. 12 indexed citations

Kuilenburg, André B. P., Godefridus J. Peters, Henk van Lenthe, et al.. (1995). 954 Circadian variation of dihydropyrimidine dehydrogenase (DPD), uridine phosphorylase (UP), β-alanine (β-ALA) and 5-fluorouracil, (5-FU) during continuous infusion (CI) fluoropyrimidines (FP). European Journal of Cancer. 31. S198–S198. 3 indexed citations

Gennip, Albert H., N. G. G. M. Abeling, A. E. M. Stroomer, Henk van Lenthe, & H. D. Bakker. (1994). Clinical and biochemical findings in six patients with pyrimidine degradation defects. Journal of Inherited Metabolic Disease. 17(1). 130–132. 40 indexed citations

10.

Gennip, A. H. van, N. G. G. M. Abeling, A. E. M. Stroomer, Henk Overmars, & H. D. Bakker. (1994). The detection of molybdenum cofactor deficiency: Clinical symptomatology and urinary metabolite profile. Journal of Inherited Metabolic Disease. 17(1). 142–145. 11 indexed citations

11.

Gennip, A. H. van, et al.. (1993). Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clinical Chemistry. 39(3). 380–385. 51 indexed citations

12.

Gennip, A. H. van, et al.. (1991). The effect of molybdenum cofactor deficiency on the purine pattern of cerebrospinal fluid. Journal of Inherited Metabolic Disease. 14(3). 364–366. 2 indexed citations

13.

Stroomer, A. E. M., Henk Overmars, N.G.G.M. Abeling, & Albert H. Gennip. (1990). Simultaneous determination of acidic 3,4-dihydroxyphenylalanine metabolites and 5-hydroxyindole-3-acetic acid in urine by high-performance liquid chromatography. Clinical Chemistry. 36(10). 1834–1837. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact